Alembic Pharmaceuticals Limited (APLLTD) — Annual Report
Alembic Pharmaceuticals announced its 16th Annual General Meeting on 5 August 2026 via video conferencing, seeking shareholder approval for audited financial statements, dividend declaration, appointment of Mr. Sujit Jaysukh Bhayani as an Independent Director, and ratification of cost auditor remuneration. The meeting will be conducted electronically with no physical attendance or proxy facility, and shareholders must update KYC and bank details to receive dividends.
About Alembic Pharmaceuticals Limited (APLLTD)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when APLLTD files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track APLLTD — Free💡 Ask AI about this filing
📊 More APLLTD filings
- 🔴 Announcement — 1 July 2026 Alembic Pharmaceuticals reaffirmed its CRISIL AA+/Stable rating on a revalued Rs. 1,100 crore bank l...
- Financial Results — 26 June 2026 Alembic Pharmaceuticals announced that its trading window will close on 1 July 2026 and remain close...
- Announcement — 26 June 2026 Alembic Pharmaceuticals announced USFDA final approval for Oseltamivir Phosphate Oral Suspension 6 m...
- Announcement — 19 June 2026 Alembic Pharmaceuticals announced that its USFDA tentative approval for Binimetinib 45 mg tablets ha...
- Announcement — 19 June 2026 Alembic Pharmaceuticals announced scheduled one-on-one investor meetings on June 22, 23, and 25, 202...
🔥 Also filed on 10 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when APLLTD files new disclosures
Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track APLLTD — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research